Humacyte, Inc.
US ˙ NasdaqGS ˙ US44486Q1031

SecurityHUMA / Humacyte, Inc.
InstitutionLPL Financial LLC
Latest Disclosed Ownership864,463 shares
Latest Disclosed Value $ 524,470
LPL Financial LLC reports 3.20% increase in ownership of HUMA / Humacyte, Inc.

On May 6, 2026 - LPL Financial LLC filed a 13F-HR form disclosing ownership of 864,463 shares of Humacyte, Inc. (US:HUMA) valued at $524,470 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 837,661 shares of Humacyte, Inc.. This represents a change in shares of 3.20% during the quarter. The current value of the position is $1,210,248 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F HUMACYTE COM 44486Q103 864,463 26,802 3.20 524 -34.83 0.0001
2026-02-11 2025-12-31 13F HUMACYTE COM 44486Q103 837,661 46,904 5.93 805 -41.53 0.0002
2025-11-12 2025-09-30 13F HUMACYTE COM 44486Q103 790,757 65,957 9.10 1,376 -9.18 0.0004
2025-08-12 2025-06-30 13F HUMACYTE COM 44486Q103 724,800 90,818 14.33 1,515 40.19 0.0005
2025-05-07 2025-03-31 13F HUMACYTE COM 44486Q103 633,982 103,990 19.62 1,081 -59.64 0.0004
2025-02-11 2024-12-31 13F HUMACYTE COM 44486Q103 529,992 18,000 3.52 2,676 -3.91 0.0011
2024-11-08 2024-09-30 13F HUMACYTE COM 44486Q103 511,992 48,740 10.52 2,785 25.28 0.0012
2024-08-07 2024-06-30 13F HUMACYTE COM 44486Q103 463,252 43,157 10.27 2,224 70.21 0.0011
2024-05-10 2024-03-31 13F HUMACYTE COM 44486Q103 420,095 52,550 14.30 1,306 25.22 0.0007
2024-02-14 2023-12-31 13F HUMACYTE COM 44486Q103 367,545 26,063 7.63 1,044 4.30 0.0006
2023-11-13 2023-09-30 13F HUMACYTE COM 44486Q103 341,482 25,342 8.02 1,001 10.62 0.0007
2023-07-31 2023-06-30 13F HUMACYTE COM 44486Q103 316,140 37,300 13.38 904 4.99 0.0006
2023-05-10 2023-03-31 13F HUMACYTE COM 44486Q103 278,840 -5,700 -2.00 862 43.50 0.0007
2023-02-07 2022-12-31 13F HUMACYTE COM 44486Q103 284,540 -28,500 -9.10 600 -41.23 0.0005
2022-11-14 2022-09-30 13F HUMACYTE COM 44486Q103 313,040 15,500 5.21 1,021 6.91 0.0010
2022-08-12 2022-06-30 13F HUMACYTE COM 44486Q103 297,540 297,540 955 0.0009
2022-05-16 2022-03-31 13F HUMACYTE COM 44486Q103 0 -238,865 -100.00 0 -100.00
2022-02-14 2021-12-31 13F HUMACYTE COM 44486Q103 238,865 124,250 108.41 1,732 30.13 0.0015
2021-11-15 2021-09-30 13F HUMACYTE COM 44486Q103 114,615 114,615 1,331 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.